SCHEMBL381522

SCHEMBL381522

CCS(=O)(=O)NCC(c1cccc(Cl)c1Cl)N(C(=O)O)C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
MAPK1 P28482 1/20 0.34
ITGAV P06756 1/20 0.34
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
TAS1R2 Q8TE23 1/20 0.34
OPRM1 P35372 3/20 0.33
CXCR2 P25025 1/20 0.33
MAPK14 Q16539 1/20 0.33
CXCL8 P10145 1/20 0.33
PDK1 Q15118 1/20 0.33
PDK2 Q15119 1/20 0.33
PDK3 Q15120 1/20 0.33
PDK4 Q16654 1/20 0.33
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33
CYP2D6 P10635 1/20 0.33
NFKB1 P19838 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19244883 0.91 OPRM1 (0.41) MEN1KMT2AOPRM1CXCL8ADRB2
SCHEMBL380995 0.90 KMT2A (0.36) MEN1KMT2AITGAVOPRM1CXCL8
SCHEMBL417713 0.82 OPRM1 (0.38) MEN1KMT2AMAPK1ITGAVTAS1R3
SCHEMBL19244878 0.81 OPRM1 (0.39) MEN1KMT2AOPRM1CXCL8ADRB2
SCHEMBL19244855 0.80 MEN1 (0.41) MEN1KMT2AMAPK1TAS1R3TAS1R1
SCHEMBL19244867 0.80 OPRM1 (0.42) OPRM1CXCL8ADRB2ADRB1CYP2D6
SCHEMBL382150 0.80 CNR2 (0.39) MEN1KMT2AMAPK1HSD11B1ALDH1A1
SCHEMBL381393 0.79 NISCH (0.43) MEN1KMT2AMAPK1TAS1R3TAS1R1
SCHEMBL381228 0.78 MEN1 (0.39) MEN1KMT2AMAPK1TAS1R3TAS1R1
SCHEMBL19244879 0.78 MEN1 (0.37) MEN1KMT2AMAPK1TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408751-B1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof BAYER IP GMBH (DE) 2017-08-23 EP disclosed
EP-2408751-A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed